5317682026-01-012026-03-315317682026-03-315317682025-03-315317682025-04-012026-03-315317682026-01-012026-03-31in-capmkt:OtherExpenses1Member5317682026-01-012026-03-31in-capmkt:OtherExpenses2Member5317682025-04-012026-03-31in-capmkt:OtherExpenses1Member5317682025-04-012026-03-31in-capmkt:OtherExpenses2Member5317682026-03-31OtherNoncurrentFinancialAssetsDomain15317682026-03-31OtherNoncurrentAssetsDomain15317682026-03-31OtherNoncurrentAssetsDomain25317682026-03-31OtherCurrentFinancialAssetsDomain15317682026-03-31OtherCurrentAssetsDomain15317682026-03-31OtherNoncurrentFinancialLiabilitiesDomain15317682026-03-31OtherNoncurrentFinancialLiabilitiesDomain25317682026-03-31OtherNoncurrentLiabilitiesDomain15317682026-03-31OtherCurrentFinancialLiabilitiesDomain15317682026-03-31OtherCurrentFinancialLiabilitiesDomain25317682026-03-31OtherCurrentLiabilitiesDomain15317682026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15317682025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15317682026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15317682025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15317682026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares531768POLYMEDNAINE205C01021POLY MEDICURE LIMITEDMain BoardEquity2025-04-012026-03-312026-05-252026-05-14INRLakhsQuarterlyFourth quarterSingle segmentManufacturing of Medical Devices2026-05-2512:00:002026-05-2515:00:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated53451140001775650005522679000155078000013842000216997000126141000064086000382320000119811200046875470008351320000835132000254414000-52602000201812000063332000000017090000650410000248980000899390000662919000-12509000912218000-1282800050679700056.546.53006.546.531.The above audited standalone and consolidated results were reviewed and recommended by the Audit Committee & approved by the Board of Directors at their respective meetings held on 25th May, 2026. The statutory auditors have expressed an unmodified audit opinion on these standalone and consolidated financial results. <BR> 2.The standalone and consolidated financial results have been prepared in accordance with the principles and procedures of Indian Accounting Standards ("Ind AS") as notified under the Companies (Indian Accounting Standards) Rules, 2015 as specified in section 133 of the Companies Act, 2013. <BR> 3.The consolidated financial results of the company and its foreign subsidiaries/Indian subsidiary ("Group") and associate have been prepared as per IND AS 110 “Consolidated Financial Statements” and IND AS 28 on “Investment in Associates”. The entities whose audited and management certified financial statements have been included in consolidated financial statements are as annexed. <BR> 4.In line with the provisions of Ind AS 108 "Operating Segments" and on the basis of review of operations being done by the management of the company, the operations of the group falls under medical devices, which is considered to be the only reportable segment by the management. <BR> <BR> 2025-04-012026-03-31AuditedConsolidated18752592000120082200019953414000599387000050605000-76363000402255900018290700011551660004338756000156675000004285914000-68040000421787400010146010005281100010674120000315046200000056837000320729900046485900036721580003221396000-140970003686564000-1440600050679700053055493000031.7931.750031.7931.75Research and development expenses67429000Other expenses1130683000Research and development expenses298759000Other expenses4039997000125515090009051370002737871000157094800082014000015177900060540000018593300019198700073642600084066900019768340000433840700073915740005311727000512282000366418000744300045499700014044441000010344840001941733200039185672000506797000305549300003106172700043070500031492432000520877000000410946000931823000310670000579690000157580001000750001938016000289529800015965800010669930001226651000957381000507933000056429500025603000859960000575522400000769324000039185672000Other Financial assets185933000Right of use Asset79565000Other non-current assets761104000Other financial assets454997000Other current assets1034484000Lease Liabilities51611000Other Financial Liability359335000Other non-current liabilities100075000Lease Liabilities67973000Other Financial Liabilities889408000Other current liabilities564295000182907000-371881000-9931040000-346361000-31259000-139920003004900001222410000261746000100075000115516600002463600078903000-99209000-251018000-11670000086380009914300074088000-528326000000362970000-793523000342435100000010174420000240690900004191865000000000258330003083919000000000000004817749000000004020600013818500000-225381100000000033780000745677000033299000354310000159932000002015140003546120001384500036845700086988000455445000Remeasurement of defined benefit obligations83970008397000Remeasurement of defined benefit obligations302300030230002114000761000Exchange differences on translation of financial statements of foreign Subsidiaries242697000242697000Exchange differences on translation of financial statements of foreign Subsidiaries46259700046259700000248980000464859000AuditedtrueDoogar & Associatestrue2028-03-31